EUVIMEDEUVIMED entdecken
Open Access · CC BY-NC-ND 4.0

Predictors of glycaemic improvement in children and young adults with type 1 diabetes and very elevated HbA1c using the MiniMed 780G system

Yongwen Zhou iD, Alisa Boucsein iD, Venus R Michaels iD, Madeleine K Gray, Craig Jefferies iD, Esko Wiltshire iD, Ryan G Paul iD, Amber Parry-Strong iD, Maheen Pasha, Goran Petrovski iD, Martin I de Bock iD, Benjamin J Wheeler iD

Diabetes, Obesity and Metabolism · 2025

DOI: 10.1111/dom.16210 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Diabetes, Obesity and Metabolism, 2025. Verfasst von Yongwen Zhou und 11 weiteren Autor:innen. Beteiligte Einrichtung: Department of Women's and Children's Health, University of Otago, Dunedin, New Zealand. Hauptthemen laut MEDLINE: Diabetes Mellitus, Type 1, Glycated Hemoglobin, Insulin, Insulin Infusion Systems. Die Arbeit wurde bisher 11-mal zitiert (Crossref) und nennt 34 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0). Gefördert von: Lions New Zealand District 202F, Lloyd Morgan Lions Clubs Charitable Trust, Otago Southland Diabetes Research Trust.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Aims

This study aimed to identify key factors with the greatest influence on glycaemic outcomes in young individuals with type 1 diabetes (T1D) and very elevated glycaemia after 3 months of automated insulin delivery (AID). Materials and Methods Data were combined and analysed from two separate and previously published studies with similar inclusion criteria assessing AID (MiniMed 780G) efficacy among young individuals naïve to AID (aged 7–25 years) with glycated haemoglobin A1c (HbA1c) ≥69 mmol/mol (≥8.5%). Univariate and multivariate linear models were performed to explore factors leading to the greatest improvements in HbA1c and time in range 3.9–10.0 mmol/L (70–180 mg/dL; TIR).

Results

A total of 99 young individuals (aged 17.3 ± 4.2 years; baseline HbA1c 92 ± 21 mmol/mol [10.6% ± 1.9%]) were included. After 3 months of AID use, HbA1c improved to 65 ± 16 mmol/mol (8.1% ± 1.5%) (−27 ± 23 mmol/mol; −2.5% ± 2.1% change), and TIR improved from 24.2% ± 13.5% to 58.4% ± 15.4% ( p both 100 mmol/mol [>11.0%]) and high time in automation mode (>80%), which led to decreased HbA1c by 27.0 mmol/mol (2.4%) and 14.2 mmol/mol (1.3%) and increased TIR by 6.1% and 11.1% ( p all 3 times/day and glucose target of 5.5 mmol/L (100 mg/dL) also led to significant increases in TIR. No other factors, including age, prior use of multiple daily injection, ethnicity, gender and optimal active insulin time 2 h, contributed to statistically significant HbA1c or TIR improvement.

Conclusions

In young individuals naive to AID, those with the highest baseline HbA1c and high percentage time in automation experience the greatest benefits after initiation of AID. Sociodemographic background and carbohydrate counting adherence/knowledge should not prevent or delay access to AID technology (ACTRN12621000556842 and ACTRN12622001454763).

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Diabetes Mellitus, Type 1Glycated HemoglobinInsulinInsulin Infusion SystemsHypoglycemic AgentsGlycemic ControlHumansAdolescentChildMaleFemaleYoung AdultBlood GlucoseAdultTreatment OutcomeBlood Glucose Self-Monitoring

Stichwörter der Autor:innen

automated insulin deliverychildren and adolescentstype 1 diabetes mellitus

Substanzen

Glycated HemoglobinInsulinHypoglycemic AgentsBlood Glucosehemoglobin A1c protein, human

Autor:innen und Institutionen

  • Department of Women's and Children's Health, University of Otago, Dunedin, New Zealand.
  • The Third Affiliated Hospital of Sun Yat-sen University, Guangdong Provincial Key Laboratory of Diabetology, Guangzhou, China.
  • Starship Child Health, Te Whatu Ora Te Toka Tumai Auckland, Auckland, New Zealand.
  • Liggins Institute and Department of Paediatrics, The University of Auckland, Auckland, New Zealand.
  • Department of Paediatrics and Child Health, University of Otago Wellington, Wellington, New Zealand.
  • Te Whatu Ora Capital, Coast and Hutt Valley, Wellington, New Zealand.

ORCID-Profile: Yongwen Zhou, Alisa Boucsein, Venus R Michaels, Craig Jefferies, Esko Wiltshire, Ryan G Paul, Amber Parry-Strong, Goran Petrovski, Martin I de Bock, Benjamin J Wheeler

Förderung

  • Lions New Zealand District 202F
  • Lloyd Morgan Lions Clubs Charitable Trust
  • Otago Southland Diabetes Research Trust
  • New Zealand Lottery Grants Board
  • The Bowen Family
  • Spinal Cord Society of New Zealand
  • University of Otago Wellington
  • Starship Foundation

Zitieren

APA

Zhou, Y., Boucsein, A., Michaels, V. R., Gray, M. K., Jefferies, C., Wiltshire, E., Paul, R. G., Parry-Strong, A., Pasha, M., Petrovski, G., de Bock, M. I., & Wheeler, B. J. (2025). Predictors of glycaemic improvement in children and young adults with type 1 diabetes and very elevated HbA1c using the MiniMed 780G system. Diabetes, Obesity and Metabolism. https://doi.org/10.1111/dom.16210

Vancouver

Zhou Y, Boucsein A, Michaels VR, Gray MK, Jefferies C, Wiltshire E, et al. Predictors of glycaemic improvement in children and young adults with type 1 diabetes and very elevated HbA1c using the MiniMed 780G system. Diabetes, Obesity and Metabolism. 2025. doi:10.1111/dom.16210

BibTeX
@article{Zhou2025,
  author = {Zhou, Yongwen and Boucsein, Alisa and Michaels, Venus R and Gray, Madeleine K and Jefferies, Craig and Wiltshire, Esko and Paul, Ryan G and Parry-Strong, Amber and Pasha, Maheen and Petrovski, Goran and de Bock, Martin I and Wheeler, Benjamin J},
  title = {Predictors of glycaemic improvement in children and young adults with type 1 diabetes and very elevated HbA1c using the MiniMed 780G system},
  journal = {Diabetes, Obesity and Metabolism},
  year = {2025},
  doi = {10.1111/dom.16210}
}
Kostenlos starten →